A detailed history of Grandeur Peak Global Advisors, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Grandeur Peak Global Advisors, LLC holds 52,625 shares of DXCM stock, worth $4.22 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares
52,625
Previous 26,070 101.86%
Holding current value
$4.22 Million
Previous $2.96 Million 19.32%
% of portfolio
0.31%
Previous 0.25%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$64.0 - $116.06 $1.7 Million - $3.08 Million
26,555 Added 101.86%
52,625 $3.53 Million
Q2 2024

Aug 14, 2024

SELL
$110.31 - $140.45 $68,502 - $87,219
-621 Reduced 2.33%
26,070 $2.96 Million
Q1 2024

May 15, 2024

SELL
$114.22 - $140.1 $286,463 - $351,370
-2,508 Reduced 8.59%
26,691 $3.7 Million
Q4 2023

Feb 13, 2024

SELL
$75.49 - $124.16 $341,516 - $561,699
-4,524 Reduced 13.42%
29,199 $3.62 Million
Q3 2023

Nov 14, 2023

BUY
$86.06 - $137.93 $1.34 Million - $2.15 Million
15,615 Added 86.23%
33,723 $3.15 Million
Q1 2023

May 12, 2023

BUY
$104.0 - $122.92 $197,600 - $233,548
1,900 Added 11.72%
18,108 $2.1 Million
Q4 2022

Feb 13, 2023

SELL
$84.98 - $122.67 $840,452 - $1.21 Million
-9,890 Reduced 37.9%
16,208 $1.84 Million
Q3 2022

Nov 17, 2022

BUY
$76.35 - $94.18 $237,143 - $292,523
3,106 Added 13.51%
26,098 $2.1 Million
Q2 2022

Aug 15, 2022

BUY
$67.99 - $132.89 $1.36 Million - $2.66 Million
19,999 Added 668.19%
22,992 $1.71 Million
Q1 2022

May 13, 2022

BUY
$94.08 - $130.2 $134,534 - $186,185
1,430 Added 91.49%
2,993 $1.53 Million
Q4 2021

Feb 15, 2022

SELL
$129.87 - $162.82 $25,974 - $32,564
-200 Reduced 11.34%
1,563 $839,000
Q3 2021

Nov 16, 2021

SELL
$106.71 - $143.18 $17,287 - $23,195
-162 Reduced 8.42%
1,763 $964,000
Q2 2021

Aug 17, 2021

BUY
$80.99 - $107.93 $48,594 - $64,758
600 Added 45.28%
1,925 $822,000
Q1 2021

May 18, 2021

BUY
$84.79 - $104.74 $55,113 - $68,081
650 Added 96.3%
1,325 $476,000
Q4 2020

Feb 16, 2021

BUY
$78.0 - $104.5 $23,400 - $31,350
300 Added 80.0%
675 $250,000
Q3 2020

Nov 17, 2020

SELL
$95.51 - $112.95 $45,367 - $53,651
-475 Reduced 55.88%
375 $155,000
Q2 2020

Aug 13, 2020

SELL
$62.68 - $105.34 $10,969 - $18,434
-175 Reduced 17.07%
850 $345,000
Q1 2020

May 18, 2020

SELL
$47.79 - $75.63 $48,984 - $77,520
-1,025 Reduced 50.0%
1,025 $276,000
Q4 2019

Feb 14, 2020

SELL
$36.62 - $57.29 $51,268 - $80,206
-1,400 Reduced 40.58%
2,050 $448,000
Q4 2018

Feb 14, 2019

SELL
$26.99 - $37.37 $22,941 - $31,764
-850 Reduced 19.77%
3,450 $413,000
Q3 2018

Nov 14, 2018

SELL
$23.35 - $36.72 $49,035 - $77,112
-2,100 Reduced 32.81%
4,300 $615,000
Q4 2017

Feb 22, 2018

BUY
$11.12 - $15.38 $71,168 - $98,432
6,400
6,400 $367,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Grandeur Peak Global Advisors, LLC Portfolio

Follow Grandeur Peak Global Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grandeur Peak Global Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Grandeur Peak Global Advisors, LLC with notifications on news.